Successful Management of Checkpoint Inhibitor-Induced Arthritis With Disease-Modifying Antirheumatic Drugs During Active Immune Checkpoint Inhibition Treatment

Affiliations

• ¹ Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg; helga.bjork.brynjarsdottir@gu.se.
• ² Department of Rheumatology, Sahlgrenska University Hospital.
• ³ Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg.
• ⁴ Department of Oncology, Sahlgrenska University Hospital.
• ⁵ Department of Molecular and Clinical Medicine/Wallenberg Laboratory, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
• ⁶ Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg.